LightForce Orthodontics Secures $50 Million Series C Funding

Funds to be used to further development of 3D printing technology to create custom orthodontic treatments for every patient

LightForce Orthodontics, makers of the world’s only fully customizable 3D printed braces system, today announced that the company raised a $50 million Series C round led by Kleiner Perkins.

Previous LightForce Orthodontics investors also participated in this round, including Matrix Partners, Tyche Partners, and AM Ventures. The investment follows on the heels of LightForce posting over a 500% revenue growth rate during the past year in which the company developed two new products and grew their team year over year by 300%.

The new funds will allow LightForce Orthodontics to offer training and education to orthodontists so that they are maximizing the technology for their patients while scaling operations and go-to-market efforts. Orthodontic practices around the country will work with LightForce to combine the digital benefits seen with aligner therapy with the tooth-moving efficiency and quality outcomes seen with braces.

“LightForce Orthodontics was founded to provide fully customized, USA-made treatment options for orthodontists interested in offering modern braces to their patients,” said LightForce CEO and co-founder Dr. Alfred Griffin III, DMD, PhD, MMSc. “The investment from Kleiner Perkins allows us to continue creating mass-customized braces that enable orthodontists to provide a personalized patient experience within an industry that has not evolved the use of braces in the last 25 years. In fact, without LightForce, patients today would likely be wearing the same sort of braces their parents did back when they were teenagers. With these new funds, LightForce will further champion the unmet needs of the modern teen market by complimenting aligner cases and allowing orthodontists to take their practices fully digital, while capitalizing on the advancement of 3D printing technology, modern materials, and advanced application-specific CAD software. A patient’s teeth are all unique as snowflakes, and now orthodontists have the technology to account for that individualism in their treatment plan, just as they have with their aligner cases. We are excited to continue implementing 3D printing technology in orthodontics in new and innovative ways to create a new standard of care for all braces patients.”

Since no set of teeth is the same and 70% of patients require braces instead of aligners, LightForce’s 3D printing technology enables complete and infinite personalization for each patient. One of LightForce’s biggest differentiators is its ability to 3D print brackets that fit the unique tooth morphology of each patient, customization that would otherwise be unavailable to patients with traditional braces. LightForce’s dynamic and modern technology provides a patient-specific alternative to traditional braces, ensuring that today’s patients will not need to endure the dated “one-size-fits-all” approach to braces that often fails to meet the patient experience and efficient clinical outcomes. As a result, patients and doctors are able to see shorter treatment times, fewer appointments, better outcomes, and an overall more efficient and comfortable experience. In an industry where precision is key, 3D printing allows orthodontists to fine tune each tooth movement down to a micron, one-thousandth of a millimeter, resulting in a balanced bite and smile tailored to each unique patient.

“LightForce’s Orthodontics innovative approach to an industry that has lacked technological disruptiveness for the past 25 years is what initially attracted us to this investment opportunity,” said Wen Hsieh, partner, Kleiner Perkins. “Having previously-invested in the first digital revolution of orthodontics decades ago through Align Technology, Kleiner Perkins is excited to invest in the second-wave of orthodontics digitization through Lightforce. We’re excited to partner with Co-Founder-CEO Alfred Griffin and the Lightforce team to leverage the latest 3D printing technology to further enhance the doctor and patient experience with bracket-based orthodontics.”

Digital customization with 3D printing offers several key advantages to doctors and patients that work with LightForce Orthodontics, including:

  • Scalable and Efficient Treatments, allowing orthodontists to reach new levels of efficiency without sacrificing product quality or patient comfort.
  • Patient-Specific Prescriptions means that treatment plans are designed with proprietary software, combined with advanced 3D printing technology, to create precise and fully custom treatments for every patient.
  • Digitizing Fixed Appliances bring the planning simplicity, practice consistency and ease of use seen today in direct-to-consumer aligners into the world of fixed dental appliances.

In the last year, LightForce Orthodontics has developed additional orthodontic advancements such as the Light Bracket, which is their line of translucent braces. The Light Bracket is a more aesthetic option that blends in with the color of a patient’s teeth, reducing the visibility of the overall system.


Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

MMI notes the funds will support commercialization of the Symani® Surgical System in high-growth markets and continued investment in studies that generate clinical evidence and enable indication expansion. Investments will also accelerate advanced technology capabilities and enable MMI to scale its operational capabilities globally.
“We are excited to begin our journey as a public company with this additional investment. We believe Tevogen’s patient-centric approach, which merges a focus on affordability with advanced science, is a blueprint for sustainable success in the current era of healthcare. I am pleased that investors now have the opportunity to participate in Tevogen’s mission to become the very first life science company offering commercially attractive and affordable personalized T cell therapies for large patient populations in virology, oncology, and neurology, said the CEO of Tevogen Bio.
MB2 Dental notes the financing will be used to fund upcoming acquisitions and future growth for the company, following a record year of growth in 2023 with 150 new partnerships.
Procyrion notes the funding will support the DRAIN-HF pivotal IDE trial evaluating the company's Aortix pump, internal R&D programs to improve manufacturability, and commercialization preparation.
PhotoniCare, in January of this year, announced that the U.S. Food and Drug Administration had granted clearance for its TOMi™ Scope for non-invasive imaging of the middle ear.

By using this website you agree to accept Medical Device News Magazine Privacy Policy